For Veterinarians
Overview for Veterinarians
- What We Regulate
- Laws We Enforce
- Types of FDA Regulatory Action
- Animal Drugs
- Unapproved Animal Drugs
- Animal Feed
- Antiparasitic Resistance
- Contact CVM
- Glossary
Articles
New Antiparasitic Drugs Needed for Small Ruminants What Veterinarians Should Tell Clients About Pain Control and Their Pets Conditional Approval Explained: A Resource for Veterinarians FDA Provides Equine Veterinarians with Important Information about TILDREN and OSPHOS for Navicular Syndrome in Horses FDA Provides Important Information to Veterinarians about PACCAL VET-CA1 for Treating Cancer in Dogs A Microgram of Prevention is Worth a Milligram of Cure: Preventing Medication Errors in Animals Potassium Bromide: Is It Safe for Dogs? A Systematic Review of the Safety of Potassium Bromide in Dogs (JAVMA, Vol 240, No. 6, March 15, 2012) (PDF - 670KB)Concerns about marketed but unapproved animal drugs (JAVMA, Vol 240, No. 9, May 1, 2012) (PDF - 187KB)The Ins and Outs of Extra-Label Drug Use in Animals: A Resource for Veterinarians Antiparasitic resistance and grazing livestock in the United States (JAVMA, Vol 244, No. 9, May 1, 2014)
"Dear Veterinarian" Letters
Letters issued to veterinarians by the FDA CVM alerting them to important information regarding approved new animal drugs and other veterinary products.
- VETORYL (trilostane) Capsules
- Phenylbutazone in Horses
- EQUIDONE (domperidone) Gel
- SucroMate Equine (deslorelin acetate)
- INCURIN (estriol) Tablets and PROIN (phenylpropanolamine hydrochloride) Chewable Tablets
- PRASCEND (pergolide mesylate) Tablets
- GONAbreed
- FACTREL
- Jerky Pet Treats
Kinavet-CA1 (mastinib mesylate)
Product Safety Information
Dear Doctor Letters
Letters issued to veterinary medicine professionals by drug manufacturers alerting the professionals to important safety information.Adverse Drug Experience (ADE) Reports
Adverse Drug Experience ReportingRisk Minimization Action Plans (RiskMAPs) for Approved Products